Autoimmune Hemolytic Anemia

DBCOND0028381Cardiovascular DiseasesHemic and Lymphatic Diseases

Autoimmune Hemolytic Anemia is the indication for 4 drugs in DrugBank. It is covered by 4 curated, structured indications.

Also known as
Anemia, Hemolytic, Autoimmune · Autoimmune haemolytic anaemia · auto-immune hemolytic anemia
Classified under
Indicated drugs

Resolves to

Vocabularies
MeSHM0001127SNOMED CT154803002MedDRA10002046UMLSC0002880

What you can answer from here — as of October 22, 2026

4Indicated drugsWith each drug's targets and mechanism
Listed above
4Structured indicationsPopulation, line of therapy, route and combination as fields, not prose
Sign in
94Clinical trialsPhase, status and sponsor resolved per trial
Sign in
10Drugs reporting it as an adverse effectWith incidence where the label states it
Sign in

Which approved drugs for Autoimmune Hemolytic Anemia share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In